XTX Topco Ltd - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$783,954
+143.9%
38,093
+457.3%
0.13%
+131.0%
Q2 2023$321,382
+53.6%
6,835
+37.0%
0.06%
+31.8%
Q1 2023$209,296
-21.0%
4,988
-16.7%
0.04%
-50.6%
Q3 2021$265,000
-19.0%
5,991
+4.0%
0.09%
-19.1%
Q2 2021$327,0005,7630.11%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders